Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families

Journal of Medical Genetics

Volumn 34, Issue 11, 1997, Pages 884-888

  Hamann, Ute ^a   Häner, Michele ^b   Stosiek, Ulrich ^c   Bastert, Guther ^d   Scott, Rodney J ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Diakonissenkrankenhaus   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

BRCA1; Breast ovarian cancer; Germline mutations

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER FAMILY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRAMESHIFT MUTATION; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONSENSE MUTATION; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; RNA SPLICING; TUMOR SUPPRESSOR GENE;

EID: 0030777784     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.34.11.884     Document Type: Article

References (30)

1. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;50:1684-9.
2. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
3. Futreal PA, Liu Q, Shattuck-Eidens D, et al BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
4. Castilla LH, Couch FJ, Erdos MR, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 1994;8:387-91.
5. Simard J, Tonin P, Durocher F, et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 1994;8:392-8.
6. Friedman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994; 8:399-404.
7. Johannsson O, Ostermeyer EA, Häkansson S, et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am J Hum Genet 1996;58: 441-50.
8. Serova O, Montagna M, Torchard D, et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 1996;58:42-51.
9. Hogervorst FBL, Cornelis RS, Bout M, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 1995;10:208-12.
10. Plummer SJ, Anton-Culver H, Webster L, et al. Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet 1995;10:1989-91.
11. Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995;57:1-7.
12. Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
13. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet 1994;343:692-5.
14. Smith SA, Easton DF, Evans DGR, Ponder BAJ. Allele losses in the region 17q12-q21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992;2:128-31.
15. Cornelis RS, Neuhausen SL, Johansson O, et al. High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families. Genes Chrom Cancer 1995;13:203-10.
16. Hosking L, Trowsdale J, Nicolai H, et al. A somatic BRCA1 mutation in an ovarian tumour. Nat Genet 1995;9:343-4.
17. Merajver SD, Pham TM, Caduff RF, et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 1995;9:439-43.
18. Gudas JM, Nguyen H, Li T, Cowan KH. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 1995;55:4561-5.
19. Lane TF, Deng C, Elson A, Lyu MS, Kozak CA, Leder P. Expression of Brcal is associated with terminal differentia-tion of ectodermally and mesodermally derived tissues in mice. Genes Div 1995;9:2712-22.
20. Marquis ST, Rajan JV, Wynshaw-Boris A, et al. The developmental pattern of Brcal expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995;11:17-26.
21. Wu LC, Wang ZW, Tsan JT, et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 1996;14:430-40.
22. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995;273:535-41.
23. Hamann U, Brauch H, Garvin AM, Basten G, Scott RJ. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene. Genes Chrom Cancer 1997;18:126-32.
24. Hamann U, Becher H, Zimmermann T, Pella K, Bastert G, Chang-CIaude J. German family study on hereditary breast-ovarian cancer. J Med Genet 1996;33:633-5.
25. Weber JL, Kwitek AE, May PE, Wallace MR, Collins FS, Ledbetter DH. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res 1990;18: 4640.
26. Hall JM, Friedman L, Guenther C, et al. Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 1992;50:1235-42.
27. Goldgar DE, Fields P, Lewis CM, et al A large kindred with 17q-Iinked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst 1994;86:200-9.
28. Weber JL, May PE. Abundant class of DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388-96.
29. Jandrig B, Grade K, Seitz S, et al. BRCA1 mutations in German breast-cancer families. Int J Cancer 1996;68:188-92.
30. Szabo CI, Wagner LA, Francisco LV, et al. Human, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet 1996;5:1289-98.